Global Temporal Arteritis Market Research Report 2025(Status and Outlook)

March 2025 | 170 pages | ID: G19DF4CBD7E0EN
Bosson Research

Abstracts

Report Overview

Temporal arteritis is also known as Horton's arteritis and is considered to be a severe form of vasculitis which means inflammation of the blood vessels. It is a potentially life-threatening inflammatory condition of the arteries. It can cause scalp tenderness and headaches. This condition usually occurs in temporal arteries and may occur in any medium to large artery of the body. As this condition generally occurs in aged population, it is also known as arteritis of the aged. Other names of temporal arteritis includes Horton disease, arteritis cranialis, and granulomatous arteritis.

This report provides a deep insight into the global Temporal Arteritis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Temporal Arteritis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Temporal Arteritis market in any manner.

Global Temporal Arteritis Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis AG

Endo International Inc

Teva Pharmaceutical Industries Ltd

Glenmark Pharmaceuticals Ltd

Cipla Inc

Dr Reddy's Laboratories Ltd

Abbott

F. Hoffmann -La Roche Ltd

Pfizer Inc

Zydus Group

Lupin

Amorphex Therapeutics Holdings

Inc

Bausch Health Companies Inc

Regeneron Pharmaceuticals Inc

Astellas Pharma Inc

Market Segmentation (by Type)

Oral

Parenteral

Market Segmentation (by Application)

Hospital

Home Care

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Temporal Arteritis Market
• Overview of the regional outlook of the Temporal Arteritis Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Temporal Arteritis Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Temporal Arteritis
1.2 Key Market Segments
  1.2.1 Temporal Arteritis Segment by Type
  1.2.2 Temporal Arteritis Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 TEMPORAL ARTERITIS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Temporal Arteritis Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Temporal Arteritis Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 TEMPORAL ARTERITIS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Temporal Arteritis Product Life Cycle
3.3 Global Temporal Arteritis Sales by Manufacturers (2020-2025)
3.4 Global Temporal Arteritis Revenue Market Share by Manufacturers (2020-2025)
3.5 Temporal Arteritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Temporal Arteritis Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Temporal Arteritis Manufacturing Sites, Area Served, Product Type
3.8 Temporal Arteritis Market Competitive Situation and Trends
  3.8.1 Temporal Arteritis Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Temporal Arteritis Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 TEMPORAL ARTERITIS INDUSTRY CHAIN ANALYSIS

4.1 Temporal Arteritis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF TEMPORAL ARTERITIS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Temporal Arteritis Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Temporal Arteritis Market
5.7 ESG Ratings of Leading Companies

6 TEMPORAL ARTERITIS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Temporal Arteritis Sales Market Share by Type (2020-2025)
6.3 Global Temporal Arteritis Market Size Market Share by Type (2020-2025)
6.4 Global Temporal Arteritis Price by Type (2020-2025)

7 TEMPORAL ARTERITIS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Temporal Arteritis Market Sales by Application (2020-2025)
7.3 Global Temporal Arteritis Market Size (M USD) by Application (2020-2025)
7.4 Global Temporal Arteritis Sales Growth Rate by Application (2020-2025)

8 TEMPORAL ARTERITIS MARKET SALES BY REGION

8.1 Global Temporal Arteritis Sales by Region
  8.1.1 Global Temporal Arteritis Sales by Region
  8.1.2 Global Temporal Arteritis Sales Market Share by Region
8.2 Global Temporal Arteritis Market Size by Region
  8.2.1 Global Temporal Arteritis Market Size by Region
  8.2.2 Global Temporal Arteritis Market Size Market Share by Region
8.3 North America
  8.3.1 North America Temporal Arteritis Sales by Country
  8.3.2 North America Temporal Arteritis Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Temporal Arteritis Sales by Country
  8.4.2 Europe Temporal Arteritis Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Temporal Arteritis Sales by Region
  8.5.2 Asia Pacific Temporal Arteritis Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Temporal Arteritis Sales by Country
  8.6.2 South America Temporal Arteritis Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Temporal Arteritis Sales by Region
  8.7.2 Middle East and Africa Temporal Arteritis Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 TEMPORAL ARTERITIS MARKET PRODUCTION BY REGION

9.1 Global Production of Temporal Arteritis by Region(2020-2025)
9.2 Global Temporal Arteritis Revenue Market Share by Region (2020-2025)
9.3 Global Temporal Arteritis Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Temporal Arteritis Production
  9.4.1 North America Temporal Arteritis Production Growth Rate (2020-2025)
  9.4.2 North America Temporal Arteritis Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Temporal Arteritis Production
  9.5.1 Europe Temporal Arteritis Production Growth Rate (2020-2025)
  9.5.2 Europe Temporal Arteritis Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Temporal Arteritis Production (2020-2025)
  9.6.1 Japan Temporal Arteritis Production Growth Rate (2020-2025)
  9.6.2 Japan Temporal Arteritis Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Temporal Arteritis Production (2020-2025)
  9.7.1 China Temporal Arteritis Production Growth Rate (2020-2025)
  9.7.2 China Temporal Arteritis Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Novartis AG
  10.1.1 Novartis AG Basic Information
  10.1.2 Novartis AG Temporal Arteritis Product Overview
  10.1.3 Novartis AG Temporal Arteritis Product Market Performance
  10.1.4 Novartis AG Business Overview
  10.1.5 Novartis AG SWOT Analysis
  10.1.6 Novartis AG Recent Developments
10.2 Endo International Inc
  10.2.1 Endo International Inc Basic Information
  10.2.2 Endo International Inc Temporal Arteritis Product Overview
  10.2.3 Endo International Inc Temporal Arteritis Product Market Performance
  10.2.4 Endo International Inc Business Overview
  10.2.5 Endo International Inc SWOT Analysis
  10.2.6 Endo International Inc Recent Developments
10.3 Teva Pharmaceutical Industries Ltd
  10.3.1 Teva Pharmaceutical Industries Ltd Basic Information
  10.3.2 Teva Pharmaceutical Industries Ltd Temporal Arteritis Product Overview
  10.3.3 Teva Pharmaceutical Industries Ltd Temporal Arteritis Product Market Performance
  10.3.4 Teva Pharmaceutical Industries Ltd Business Overview
  10.3.5 Teva Pharmaceutical Industries Ltd SWOT Analysis
  10.3.6 Teva Pharmaceutical Industries Ltd Recent Developments
10.4 Glenmark Pharmaceuticals Ltd
  10.4.1 Glenmark Pharmaceuticals Ltd Basic Information
  10.4.2 Glenmark Pharmaceuticals Ltd Temporal Arteritis Product Overview
  10.4.3 Glenmark Pharmaceuticals Ltd Temporal Arteritis Product Market Performance
  10.4.4 Glenmark Pharmaceuticals Ltd Business Overview
  10.4.5 Glenmark Pharmaceuticals Ltd Recent Developments
10.5 Cipla Inc
  10.5.1 Cipla Inc Basic Information
  10.5.2 Cipla Inc Temporal Arteritis Product Overview
  10.5.3 Cipla Inc Temporal Arteritis Product Market Performance
  10.5.4 Cipla Inc Business Overview
  10.5.5 Cipla Inc Recent Developments
10.6 Dr Reddy's Laboratories Ltd
  10.6.1 Dr Reddy's Laboratories Ltd Basic Information
  10.6.2 Dr Reddy's Laboratories Ltd Temporal Arteritis Product Overview
  10.6.3 Dr Reddy's Laboratories Ltd Temporal Arteritis Product Market Performance
  10.6.4 Dr Reddy's Laboratories Ltd Business Overview
  10.6.5 Dr Reddy's Laboratories Ltd Recent Developments
10.7 Abbott
  10.7.1 Abbott Basic Information
  10.7.2 Abbott Temporal Arteritis Product Overview
  10.7.3 Abbott Temporal Arteritis Product Market Performance
  10.7.4 Abbott Business Overview
  10.7.5 Abbott Recent Developments
10.8 F. Hoffmann -La Roche Ltd
  10.8.1 F. Hoffmann -La Roche Ltd Basic Information
  10.8.2 F. Hoffmann -La Roche Ltd Temporal Arteritis Product Overview
  10.8.3 F. Hoffmann -La Roche Ltd Temporal Arteritis Product Market Performance
  10.8.4 F. Hoffmann -La Roche Ltd Business Overview
  10.8.5 F. Hoffmann -La Roche Ltd Recent Developments
10.9 Pfizer Inc
  10.9.1 Pfizer Inc Basic Information
  10.9.2 Pfizer Inc Temporal Arteritis Product Overview
  10.9.3 Pfizer Inc Temporal Arteritis Product Market Performance
  10.9.4 Pfizer Inc Business Overview
  10.9.5 Pfizer Inc Recent Developments
10.10 Zydus Group
  10.10.1 Zydus Group Basic Information
  10.10.2 Zydus Group Temporal Arteritis Product Overview
  10.10.3 Zydus Group Temporal Arteritis Product Market Performance
  10.10.4 Zydus Group Business Overview
  10.10.5 Zydus Group Recent Developments
10.11 Lupin
  10.11.1 Lupin Basic Information
  10.11.2 Lupin Temporal Arteritis Product Overview
  10.11.3 Lupin Temporal Arteritis Product Market Performance
  10.11.4 Lupin Business Overview
  10.11.5 Lupin Recent Developments
10.12 Amorphex Therapeutics Holdings
  10.12.1 Amorphex Therapeutics Holdings Basic Information
  10.12.2 Amorphex Therapeutics Holdings Temporal Arteritis Product Overview
  10.12.3 Amorphex Therapeutics Holdings Temporal Arteritis Product Market Performance
  10.12.4 Amorphex Therapeutics Holdings Business Overview
  10.12.5 Amorphex Therapeutics Holdings Recent Developments
10.13 Inc
  10.13.1 Inc Basic Information
  10.13.2 Inc Temporal Arteritis Product Overview
  10.13.3 Inc Temporal Arteritis Product Market Performance
  10.13.4 Inc Business Overview
  10.13.5 Inc Recent Developments
10.14 Bausch Health Companies Inc
  10.14.1 Bausch Health Companies Inc Basic Information
  10.14.2 Bausch Health Companies Inc Temporal Arteritis Product Overview
  10.14.3 Bausch Health Companies Inc Temporal Arteritis Product Market Performance
  10.14.4 Bausch Health Companies Inc Business Overview
  10.14.5 Bausch Health Companies Inc Recent Developments
10.15 Regeneron Pharmaceuticals Inc
  10.15.1 Regeneron Pharmaceuticals Inc Basic Information
  10.15.2 Regeneron Pharmaceuticals Inc Temporal Arteritis Product Overview
  10.15.3 Regeneron Pharmaceuticals Inc Temporal Arteritis Product Market Performance
  10.15.4 Regeneron Pharmaceuticals Inc Business Overview
  10.15.5 Regeneron Pharmaceuticals Inc Recent Developments
10.16 Astellas Pharma Inc
  10.16.1 Astellas Pharma Inc Basic Information
  10.16.2 Astellas Pharma Inc Temporal Arteritis Product Overview
  10.16.3 Astellas Pharma Inc Temporal Arteritis Product Market Performance
  10.16.4 Astellas Pharma Inc Business Overview
  10.16.5 Astellas Pharma Inc Recent Developments

11 TEMPORAL ARTERITIS MARKET FORECAST BY REGION

11.1 Global Temporal Arteritis Market Size Forecast
11.2 Global Temporal Arteritis Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Temporal Arteritis Market Size Forecast by Country
  11.2.3 Asia Pacific Temporal Arteritis Market Size Forecast by Region
  11.2.4 South America Temporal Arteritis Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Temporal Arteritis by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Temporal Arteritis Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Temporal Arteritis by Type (2026-2033)
  12.1.2 Global Temporal Arteritis Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Temporal Arteritis by Type (2026-2033)
12.2 Global Temporal Arteritis Market Forecast by Application (2026-2033)
  12.2.1 Global Temporal Arteritis Sales (K Units) Forecast by Application
  12.2.2 Global Temporal Arteritis Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Temporal Arteritis Market Size Comparison by Region (M USD)
Table 5. Global Temporal Arteritis Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Temporal Arteritis Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Temporal Arteritis Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Temporal Arteritis Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Temporal Arteritis as of 2024)
Table 10. Global Market Temporal Arteritis Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Temporal Arteritis Manufacturing Sites and Area Served
Table 12. Manufacturers Temporal Arteritis Product Type
Table 13. Global Temporal Arteritis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Temporal Arteritis Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Temporal Arteritis Sales by Type (K Units)
Table 25. Global Temporal Arteritis Market Size by Type (M USD)
Table 26. Global Temporal Arteritis Sales (K Units) by Type (2020-2025)
Table 27. Global Temporal Arteritis Sales Market Share by Type (2020-2025)
Table 28. Global Temporal Arteritis Market Size (M USD) by Type (2020-2025)
Table 29. Global Temporal Arteritis Market Size Share by Type (2020-2025)
Table 30. Global Temporal Arteritis Price (USD/Unit) by Type (2020-2025)
Table 31. Global Temporal Arteritis Sales (K Units) by Application
Table 32. Global Temporal Arteritis Market Size by Application
Table 33. Global Temporal Arteritis Sales by Application (2020-2025) & (K Units)
Table 34. Global Temporal Arteritis Sales Market Share by Application (2020-2025)
Table 35. Global Temporal Arteritis Market Size by Application (2020-2025) & (M USD)
Table 36. Global Temporal Arteritis Market Share by Application (2020-2025)
Table 37. Global Temporal Arteritis Sales Growth Rate by Application (2020-2025)
Table 38. Global Temporal Arteritis Sales by Region (2020-2025) & (K Units)
Table 39. Global Temporal Arteritis Sales Market Share by Region (2020-2025)
Table 40. Global Temporal Arteritis Market Size by Region (2020-2025) & (M USD)
Table 41. Global Temporal Arteritis Market Size Market Share by Region (2020-2025)
Table 42. North America Temporal Arteritis Sales by Country (2020-2025) & (K Units)
Table 43. North America Temporal Arteritis Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Temporal Arteritis Sales by Country (2020-2025) & (K Units)
Table 45. Europe Temporal Arteritis Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Temporal Arteritis Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Temporal Arteritis Market Size by Region (2020-2025) & (M USD)
Table 48. South America Temporal Arteritis Sales by Country (2020-2025) & (K Units)
Table 49. South America Temporal Arteritis Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Temporal Arteritis Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Temporal Arteritis Market Size by Region (2020-2025) & (M USD)
Table 52. Global Temporal Arteritis Production (K Units) by Region(2020-2025)
Table 53. Global Temporal Arteritis Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Temporal Arteritis Revenue Market Share by Region (2020-2025)
Table 55. Global Temporal Arteritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Temporal Arteritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Temporal Arteritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Temporal Arteritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Temporal Arteritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Novartis AG Basic Information
Table 61. Novartis AG Temporal Arteritis Product Overview
Table 62. Novartis AG Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Novartis AG Business Overview
Table 64. Novartis AG SWOT Analysis
Table 65. Novartis AG Recent Developments
Table 66. Endo International Inc Basic Information
Table 67. Endo International Inc Temporal Arteritis Product Overview
Table 68. Endo International Inc Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Endo International Inc Business Overview
Table 70. Endo International Inc SWOT Analysis
Table 71. Endo International Inc Recent Developments
Table 72. Teva Pharmaceutical Industries Ltd Basic Information
Table 73. Teva Pharmaceutical Industries Ltd Temporal Arteritis Product Overview
Table 74. Teva Pharmaceutical Industries Ltd Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Teva Pharmaceutical Industries Ltd Business Overview
Table 76. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 77. Teva Pharmaceutical Industries Ltd Recent Developments
Table 78. Glenmark Pharmaceuticals Ltd Basic Information
Table 79. Glenmark Pharmaceuticals Ltd Temporal Arteritis Product Overview
Table 80. Glenmark Pharmaceuticals Ltd Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Glenmark Pharmaceuticals Ltd Business Overview
Table 82. Glenmark Pharmaceuticals Ltd Recent Developments
Table 83. Cipla Inc Basic Information
Table 84. Cipla Inc Temporal Arteritis Product Overview
Table 85. Cipla Inc Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Cipla Inc Business Overview
Table 87. Cipla Inc Recent Developments
Table 88. Dr Reddy's Laboratories Ltd Basic Information
Table 89. Dr Reddy's Laboratories Ltd Temporal Arteritis Product Overview
Table 90. Dr Reddy's Laboratories Ltd Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Dr Reddy's Laboratories Ltd Business Overview
Table 92. Dr Reddy's Laboratories Ltd Recent Developments
Table 93. Abbott Basic Information
Table 94. Abbott Temporal Arteritis Product Overview
Table 95. Abbott Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Abbott Business Overview
Table 97. Abbott Recent Developments
Table 98. F. Hoffmann -La Roche Ltd Basic Information
Table 99. F. Hoffmann -La Roche Ltd Temporal Arteritis Product Overview
Table 100. F. Hoffmann -La Roche Ltd Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. F. Hoffmann -La Roche Ltd Business Overview
Table 102. F. Hoffmann -La Roche Ltd Recent Developments
Table 103. Pfizer Inc Basic Information
Table 104. Pfizer Inc Temporal Arteritis Product Overview
Table 105. Pfizer Inc Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Pfizer Inc Business Overview
Table 107. Pfizer Inc Recent Developments
Table 108. Zydus Group Basic Information
Table 109. Zydus Group Temporal Arteritis Product Overview
Table 110. Zydus Group Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Zydus Group Business Overview
Table 112. Zydus Group Recent Developments
Table 113. Lupin Basic Information
Table 114. Lupin Temporal Arteritis Product Overview
Table 115. Lupin Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Lupin Business Overview
Table 117. Lupin Recent Developments
Table 118. Amorphex Therapeutics Holdings Basic Information
Table 119. Amorphex Therapeutics Holdings Temporal Arteritis Product Overview
Table 120. Amorphex Therapeutics Holdings Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Amorphex Therapeutics Holdings Business Overview
Table 122. Amorphex Therapeutics Holdings Recent Developments
Table 123. Inc Basic Information
Table 124. Inc Temporal Arteritis Product Overview
Table 125. Inc Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Inc Business Overview
Table 127. Inc Recent Developments
Table 128. Bausch Health Companies Inc Basic Information
Table 129. Bausch Health Companies Inc Temporal Arteritis Product Overview
Table 130. Bausch Health Companies Inc Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Bausch Health Companies Inc Business Overview
Table 132. Bausch Health Companies Inc Recent Developments
Table 133. Regeneron Pharmaceuticals Inc Basic Information
Table 134. Regeneron Pharmaceuticals Inc Temporal Arteritis Product Overview
Table 135. Regeneron Pharmaceuticals Inc Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Regeneron Pharmaceuticals Inc Business Overview
Table 137. Regeneron Pharmaceuticals Inc Recent Developments
Table 138. Astellas Pharma Inc Basic Information
Table 139. Astellas Pharma Inc Temporal Arteritis Product Overview
Table 140. Astellas Pharma Inc Temporal Arteritis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Astellas Pharma Inc Business Overview
Table 142. Astellas Pharma Inc Recent Developments
Table 143. Global Temporal Arteritis Sales Forecast by Region (2026-2033) & (K Units)
Table 144. Global Temporal Arteritis Market Size Forecast by Region (2026-2033) & (M USD)
Table 145. North America Temporal Arteritis Sales Forecast by Country (2026-2033) & (K Units)
Table 146. North America Temporal Arteritis Market Size Forecast by Country (2026-2033) & (M USD)
Table 147. Europe Temporal Arteritis Sales Forecast by Country (2026-2033) & (K Units)
Table 148. Europe Temporal Arteritis Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Asia Pacific Temporal Arteritis Sales Forecast by Region (2026-2033) & (K Units)
Table 150. Asia Pacific Temporal Arteritis Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. South America Temporal Arteritis Sales Forecast by Country (2026-2033) & (K Units)
Table 152. South America Temporal Arteritis Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Middle East and Africa Temporal Arteritis Sales Forecast by Country (2026-2033) & (Units)
Table 154. Middle East and Africa Temporal Arteritis Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Global Temporal Arteritis Sales Forecast by Type (2026-2033) & (K Units)
Table 156. Global Temporal Arteritis Market Size Forecast by Type (2026-2033) & (M USD)
Table 157. Global Temporal Arteritis Price Forecast by Type (2026-2033) & (USD/Unit)
Table 158. Global Temporal Arteritis Sales (K Units) Forecast by Application (2026-2033)
Table 159. Global Temporal Arteritis Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Temporal Arteritis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Temporal Arteritis Market Size (M USD), 2024-2033
Figure 5. Global Temporal Arteritis Market Size (M USD) (2020-2033)
Figure 6. Global Temporal Arteritis Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Temporal Arteritis Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Temporal Arteritis Product Life Cycle
Figure 13. Temporal Arteritis Sales Share by Manufacturers in 2024
Figure 14. Global Temporal Arteritis Revenue Share by Manufacturers in 2024
Figure 15. Temporal Arteritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Temporal Arteritis Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Temporal Arteritis Revenue in 2024
Figure 18. Industry Chain Map of Temporal Arteritis
Figure 19. Global Temporal Arteritis Market PEST Analysis
Figure 20. Global Temporal Arteritis Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Temporal Arteritis Market Share by Type
Figure 27. Sales Market Share of Temporal Arteritis by Type (2020-2025)
Figure 28. Sales Market Share of Temporal Arteritis by Type in 2024
Figure 29. Market Size Share of Temporal Arteritis by Type (2020-2025)
Figure 30. Market Size Share of Temporal Arteritis by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Temporal Arteritis Market Share by Application
Figure 33. Global Temporal Arteritis Sales Market Share by Application (2020-2025)
Figure 34. Global Temporal Arteritis Sales Market Share by Application in 2024
Figure 35. Global Temporal Arteritis Market Share by Application (2020-2025)
Figure 36. Global Temporal Arteritis Market Share by Application in 2024
Figure 37. Global Temporal Arteritis Sales Growth Rate by Application (2020-2025)
Figure 38. Global Temporal Arteritis Sales Market Share by Region (2020-2025)
Figure 39. Global Temporal Arteritis Market Size Market Share by Region (2020-2025)
Figure 40. North America Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Temporal Arteritis Sales Market Share by Country in 2024
Figure 43. North America Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Temporal Arteritis Market Size Market Share by Country in 2024
Figure 45. U.S. Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Temporal Arteritis Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Temporal Arteritis Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Temporal Arteritis Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Temporal Arteritis Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Temporal Arteritis Sales Market Share by Country in 2024
Figure 53. Europe Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Temporal Arteritis Market Size Market Share by Country in 2024
Figure 55. Germany Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Temporal Arteritis Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Temporal Arteritis Sales Market Share by Region in 2024
Figure 67. Asia Pacific Temporal Arteritis Market Size Market Share by Region in 2024
Figure 68. China Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Temporal Arteritis Sales and Growth Rate (K Units)
Figure 79. South America Temporal Arteritis Sales Market Share by Country in 2024
Figure 80. South America Temporal Arteritis Market Size and Growth Rate (M USD)
Figure 81. South America Temporal Arteritis Market Size Market Share by Country in 2024
Figure 82. Brazil Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Temporal Arteritis Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Temporal Arteritis Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Temporal Arteritis Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Temporal Arteritis Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Temporal Arteritis Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Temporal Arteritis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Temporal Arteritis Production Market Share by Region (2020-2025)
Figure 103. North America Temporal Arteritis Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Temporal Arteritis Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Temporal Arteritis Production (K Units) Growth Rate (2020-2025)
Figure 106. China Temporal Arteritis Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Temporal Arteritis Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Temporal Arteritis Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Temporal Arteritis Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Temporal Arteritis Market Share Forecast by Type (2026-2033)
Figure 111. Global Temporal Arteritis Sales Forecast by Application (2026-2033)
Figure 112. Global Temporal Arteritis Market Share Forecast by Application (2026-2033)